Literature DB >> 22166919

Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Luiz Felipe Domingues Passero1, Ana Kely Carvalho, Maria Luiza A C Bordon, Alexis Bonfim-Melo, Marcos Hikari Toyama, Carlos Eduardo Pereira Corbett, Márcia Dalastra Laurenti.   

Abstract

OBJECTIVE: Leishmania (Viannia) shawi was characterized only recently, and few studies concerning the immunogenic and protective properties of its antigens have been performed. The present study aimed to evaluate the protective potential of the five antigenic fractions isolated from L. (V.) shawi promastigotes in experimental cutaneous leishmaniasis.
MATERIALS AND METHODS: Soluble antigen from L. (V.) shawi promastigotes was submitted to reverse phase HPLC to purify F1, F2, F3, F4 and F5 antigens. BALB/c mice were immunized once a week for two consecutive weeks by subcutaneous routes in the rump, using 25 μg protein. After 1 week, groups were challenged in the footpad with L. (V.) shawi promastigotes. After 8 weeks, those same mice were sacrificed and parasite burden as well as the cellular and humoral immune responses were evaluated.
RESULTS: F1 and F5-immunized mice restrained lesion progression and parasite load in the skin. However, only the F1 group was able to control the parasitism in lymph nodes, which was associated with low IL-4 and high IFN-γ production; IgG2a isotype was increased in this group. Immunizations with F2, F3 and F4 antigens did not protect mice.
CONCLUSION: The capability of antigens to restrain IL-4 levels and increase IFN-γ was associated with protection, such as in immunization using F1 antigen.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22166919     DOI: 10.1007/s00011-011-0407-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  52 in total

Review 1.  Advances in leishmaniasis.

Authors:  Henry W Murray; Jonathan D Berman; Clive R Davies; Nancy G Saravia
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

2.  Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.

Authors:  Dalit Strauss-Ayali; Gad Baneth; Sharon Shor; Fumiyoshi Okano; Charles L Jaffe
Journal:  Int J Parasitol       Date:  2004-12-08       Impact factor: 3.981

Review 3.  Mechanism and regulation of immunoglobulin isotype switching.

Authors:  R L Coffman; D A Lebman; P Rothman
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

4.  Leishmania major: secreted antigens of Leishmania major promastigotes shift the immune response of the C57BL/6 mice toward Th2 in vitro.

Authors:  Parisa-Alsadat Tabatabaee; Mohsen Abolhassani; Mehdi Mahdavi; Hossein Nahrevanian; Kayhan Azadmanesh
Journal:  Exp Parasitol       Date:  2010-07-21       Impact factor: 2.011

5.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 6.  Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans.

Authors:  Anne-Laure Bañuls; Mallorie Hide; Franck Prugnolle
Journal:  Adv Parasitol       Date:  2007       Impact factor: 3.870

7.  Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.

Authors:  Josie Haydée L Ferreira; Luciana Girotto Gentil; Suzana Souza Dias; Carlos Eduardo C Fedeli; Simone Katz; Clara Lúcia Barbiéri
Journal:  Vaccine       Date:  2007-12-05       Impact factor: 3.641

8.  Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection.

Authors:  Haruko Ota; Yasuhiro Takashima; Yoshitsugu Matsumoto; Yoshihiro Hayashi; Yasunobu Matsumoto
Journal:  J Vet Med Sci       Date:  2008-06       Impact factor: 1.267

9.  The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.

Authors:  Abraham Aseffa; Alain Gumy; Pascal Launois; H Robson MacDonald; Jacques A Louis; Fabienne Tacchini-Cottier
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 10.  Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Authors:  Kimberly A Jordan; Christopher A Hunter
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

View more
  2 in total

1.  Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.

Authors:  Eduardo Seiji Yamamoto; Bruno Luiz S Campos; Márcia Dalastra Laurenti; João H G Lago; Simone dos Santos Grecco; Carlos E P Corbett; Luiz Felipe D Passero
Journal:  Parasitol Res       Date:  2013-10-31       Impact factor: 2.289

2.  First Report of an Asymptomatic Leishmania (Viannia) shawi Infection Using a Nasal Swab in Amazon, Brazil.

Authors:  Luciana P Oliveira; Luciana C S Nascimento; Fabiola S Santos; Jaqueline L C Takamatsu; Luiz R P Sanchez; Walter S Santos; Lourdes M Garcez
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.